Evidence map›Paper›PMID 42160310›Full record

ArticlePLoS biology2026

The Pseudomonas aeruginosa ribonuclease Ribocin cleaves eukaryotic ribosomes at helix 69 to inhibit host translation.

Alejandro Vasquez-Rifo, Denis Susorov, Emily H Sholi, Gabriel Demo, Yasaman Jami, Jihui Sha, James A Wohlschlegel, Andrei Korostelev, Victor Ambros

Abstract read
In one paragraph

Article in PLoS biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Alejandro Vasquez-RifoProgram in Molecular Medicine, UMass Chan Medical School, Worcester, Massachusetts, United States of America.ORCID https://orcid.org/0000-0003-4707-558X
Denis SusorovRNA Therapeutics Institute, UMass Chan Medical School, Worcester, Massachusetts, United States of America.
Emily H SholiRNA Therapeutics Institute, UMass Chan Medical School, Worcester, Massachusetts, United States of America.
Gabriel DemoCentral European Institute of Technology, Masaryk University, Brno, Czech Republic.ORCID https://orcid.org/0000-0002-5472-9249
Yasaman JamiDepartment of Biological Chemistry, David Geffen School of Medicine, University of California, Los Angeles, California, United States of America.
Jihui ShaDepartment of Biological Chemistry, David Geffen School of Medicine, University of California, Los Angeles, California, United States of America.
James A WohlschlegelDepartment of Biological Chemistry, David Geffen School of Medicine, University of California, Los Angeles, California, United States of America.
Andrei KorostelevRNA Therapeutics Institute, UMass Chan Medical School, Worcester, Massachusetts, United States of America.
Victor AmbrosProgram in Molecular Medicine, UMass Chan Medical School, Worcester, Massachusetts, United States of America.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pseudomonas aeruginosa employs host translation inhibition as a virulence-enhancing strategy. We previously showed that the bacterium induces cleavage of Caenorhabditis elegans large ribosomal RNA at helix 69 (H69), part of a central intersubunit bridge and the ribosomal decoding center. In this study, we demonstrate that a previously uncharacterized ribonuclease, Ribocin, is necessary and sufficient for H69 cleavage. Recombinant Ribocin cuts H69 in worm and mammalian ribosomes, indicating that H69 cleavage by P. aeruginosa is phylogenetically conserved. In worms, mammalian cells, and rabbit reticulocyte lysates, H69 cleavage results in translation inhibition. Furthermore, Ribocin contributes to bacterial virulence toward C. elegans, triggers a major host response to translation inhibition, and operates in parallel with Exotoxin A-mediated translation inhibition. These findings unveil the first known nuclease that cleaves eukaryotic ribosomes at H69 and expand the understanding of host translation-inhibition by establishing targeted rRNA cleavage as a mechanism of host attack.

Indexed as

Bacterial ProteinsProtein BiosynthesisPseudomonas aeruginosaRibosomesAnimalsCaenorhabditis elegansHost-Pathogen InteractionsRabbitsRNA, RibosomalVirulenceBacterial ProteinsRNA, Ribosomal

Identifiers

PMID42160310
PMCPMC13189344

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.